Similar articles

• Decreased neuropeptide-converting enzyme activities in cerebrospinal fluid during acute but not chronic phases of collagen induced arthritis in rats.

  Persson S, Post C, Holmdahl R, Nyberg F. Persson S, et al. Brain Res. 1992 May 29;581(2):273-82. doi: 10.1016/0006-8993(92)90718-o. Brain Res. 1992. PMID: 1382800
• Decreased cerebrospinal fluid neuropeptide-converting enzyme activity in monoarthritic rats.

  Persson S, Post C, Weil-Fugazza J, Butler SH, Nyberg F. Persson S, et al. Neurosci Lett. 1992 Aug 31;143(1-2):247-50. doi: 10.1016/0304-3940(92)90275-c. Neurosci Lett. 1992. PMID: 1279476
• Neuropeptide converting enzyme activities in CSF of low back pain patients.

  Hyyppä MT, Alaranta H, Lahtela K, Nykvist F, Hurme M, Nyberg F, Le Grevés P, Sakurada T, Terenius L. Hyyppä MT, et al. Pain. 1990 Nov;43(2):163-168. doi: 10.1016/0304-3959(90)91069-U. Pain. 1990. PMID: 2150878
• Neuropeptide-processing, -converting, and -inactivating enzymes in human cerebrospinal fluid.

  Terenius L, Nyberg F. Terenius L, et al. Int Rev Neurobiol. 1988;30:101-21. doi: 10.1016/s0074-7742(08)60047-1. Int Rev Neurobiol. 1988. PMID: 3061966 Review. No abstract available.
• Proteases and the emerging role of protease inhibitors in prohormone processing.

  Hook VY, Azaryan AV, Hwang SR, Tezapsidis N. Hook VY, et al. FASEB J. 1994 Dec;8(15):1269-78. doi: 10.1096/fasebj.8.15.8001739. FASEB J. 1994. PMID: 8001739 Review.